Wednesday , February 20 2019
Breaking News
Home / BUSINESS / Laurus Labs gets EIR from USFDA for unit 6 in Andhra Pradesh
Laurus Labs gets EIR from USFDA for unit 6 in Andhra Pradesh

Laurus Labs gets EIR from USFDA for unit 6 in Andhra Pradesh

Laurus Labs has received an Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its Unit 6 on February 2, 2019. The manufacturing unit 6 was inspected by the regulatory agency in the month of November 2018 and is located at APSEZ, Atchutapuram, Visakhapatnam in the state of Andhra Pradesh.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

Inline
if:
Inline
if: